Type |
Details |
Score |
Gene |
Type: |
gene |
Organism: |
chicken |
|
•
•
•
•
•
|
Transgene |
Type: |
transgene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Transgene |
Type: |
transgene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Transgene |
Type: |
transgene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Publication |
First Author: |
Fugger L |
Year: |
1994 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T-cell repertoire and mediates an HLA-DR-restricted immune response. |
Volume: |
91 |
Issue: |
13 |
Pages: |
6151-5 |
|
•
•
•
•
•
|
Publication |
First Author: |
Meza-Romero R |
Year: |
2014 |
Journal: |
J Immunol |
Title: |
HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis. |
Volume: |
192 |
Issue: |
9 |
Pages: |
4164-73 |
|
•
•
•
•
•
|
Publication |
First Author: |
Buenafe AC |
Year: |
2010 |
Journal: |
Immunology |
Title: |
Prevention and treatment of experimental autoimmune encephalomyelitis with clonotypic CDR3 peptides: CD4(+) Foxp3(+) T-regulatory cells suppress interleukin-2-dependent expansion of myelin basic protein-specific T cells. |
Volume: |
130 |
Issue: |
1 |
Pages: |
114-24 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
438
|
Fragment?: |
false |
|
•
•
•
•
•
|
Transgene |
Type: |
transgene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Transgene |
Type: |
transgene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Transgene |
Type: |
transgene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Transgene |
Type: |
transgene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Transgene |
Type: |
transgene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Transgene |
Type: |
transgene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Transgene |
Type: |
transgene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Publication |
First Author: |
Michno W |
Year: |
2019 |
Journal: |
J Biol Chem |
Title: |
Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology. |
Volume: |
294 |
Issue: |
17 |
Pages: |
6719-6732 |
|
•
•
•
•
•
|
Publication |
First Author: |
Michno W |
Year: |
2020 |
Journal: |
J Neurochem |
Title: |
Chemical imaging of evolving amyloid plaque pathology and associated Aβ peptide aggregation in a transgenic mouse model of Alzheimer's disease. |
Volume: |
152 |
Issue: |
5 |
Pages: |
602-616 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lillehaug S |
Year: |
2014 |
Journal: |
Neurobiol Aging |
Title: |
Brainwide distribution and variance of amyloid-beta deposits in tg-ArcSwe mice. |
Volume: |
35 |
Issue: |
3 |
Pages: |
556-64 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nuruddin S |
Year: |
2014 |
Journal: |
PLoS One |
Title: |
Elevated mRNA-levels of gonadotropin-releasing hormone and its receptor in plaque-bearing Alzheimer's disease transgenic mice. |
Volume: |
9 |
Issue: |
8 |
Pages: |
e103607 |
|
•
•
•
•
•
|
Publication |
First Author: |
Åbjørsbråten KS |
Year: |
2022 |
Journal: |
Elife |
Title: |
Impaired astrocytic Ca2+ signaling in awake-behaving Alzheimer's disease transgenic mice. |
Volume: |
11 |
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Codita A |
Year: |
2010 |
Journal: |
Behav Brain Res |
Title: |
Impaired behavior of female tg-ArcSwe APP mice in the IntelliCage: A longitudinal study. |
Volume: |
215 |
Issue: |
1 |
Pages: |
83-94 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lai JD |
Year: |
2016 |
Journal: |
Blood |
Title: |
Concurrent influenza vaccination reduces anti-FVIII antibody responses in murine hemophilia A. |
Volume: |
127 |
Issue: |
26 |
Pages: |
3439-49 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ooi JD |
Year: |
2012 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis. |
Volume: |
109 |
Issue: |
39 |
Pages: |
E2615-24 |
|
•
•
•
•
•
|
Publication |
First Author: |
Roth AJ |
Year: |
2013 |
Journal: |
J Clin Invest |
Title: |
Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis. |
Volume: |
123 |
Issue: |
4 |
Pages: |
1773-83 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jendresen C |
Year: |
2019 |
Journal: |
Sci Rep |
Title: |
Systemic LPS-induced Aβ-solubilization and clearance in AβPP-transgenic mice is diminished by heparanase overexpression. |
Volume: |
9 |
Issue: |
1 |
Pages: |
4600 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jendresen CB |
Year: |
2015 |
Journal: |
J Biol Chem |
Title: |
Overexpression of heparanase lowers the amyloid burden in amyloid-β precursor protein transgenic mice. |
Volume: |
290 |
Issue: |
8 |
Pages: |
5053-64 |
|
•
•
•
•
•
|
Publication |
First Author: |
Klyushnenkova EN |
Year: |
2012 |
Journal: |
J Immunother |
Title: |
A cytomegalovirus-based vaccine expressing a single tumor-specific CD8+ T-cell epitope delays tumor growth in a murine model of prostate cancer. |
Volume: |
35 |
Issue: |
5 |
Pages: |
390-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lord A |
Year: |
2006 |
Journal: |
Neurobiol Aging |
Title: |
The Arctic Alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in transgenic mice. |
Volume: |
27 |
Issue: |
1 |
Pages: |
67-77 |
|
•
•
•
•
•
|
Publication |
First Author: |
Philipson O |
Year: |
2009 |
Journal: |
Neurobiol Aging |
Title: |
A highly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice. |
Volume: |
30 |
Issue: |
9 |
Pages: |
1393-405 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lord A |
Year: |
2011 |
Journal: |
Am J Pathol |
Title: |
Observations in APP bitransgenic mice suggest that diffuse and compact plaques form via independent processes in Alzheimer's disease. |
Volume: |
178 |
Issue: |
5 |
Pages: |
2286-98 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1178
|
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Sosa RA |
Year: |
2013 |
Journal: |
J Immunol |
Title: |
The kinetics of myelin antigen uptake by myeloid cells in the central nervous system during experimental autoimmune encephalomyelitis. |
Volume: |
191 |
Issue: |
12 |
Pages: |
5848-57 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jansson L |
Year: |
2018 |
Journal: |
Endocrinology |
Title: |
Immunotherapy With Apitopes Blocks the Immune Response to TSH Receptor in HLA-DR Transgenic Mice. |
Volume: |
159 |
Issue: |
9 |
Pages: |
3446-3457 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ingram RJ |
Year: |
2009 |
Journal: |
FASEB J |
Title: |
A role of cellular prion protein in programming T-cell cytokine responses in disease. |
Volume: |
23 |
Issue: |
6 |
Pages: |
1672-84 |
|
•
•
•
•
•
|
Publication |
First Author: |
Henjum K |
Year: |
2020 |
Journal: |
Sci Rep |
Title: |
Analyzing microglial-associated Aβ in Alzheimer's disease transgenic mice with a novel mid-domain Aβ-antibody. |
Volume: |
10 |
Issue: |
1 |
Pages: |
10590 |
|
•
•
•
•
•
|
Publication |
First Author: |
van Hummel A |
Year: |
2018 |
Journal: |
Am J Pathol |
Title: |
Selective Spatiotemporal Vulnerability of Central Nervous System Neurons to Pathologic TAR DNA-Binding Protein 43 in Aged Transgenic Mice. |
Volume: |
188 |
Issue: |
6 |
Pages: |
1447-1456 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sehlin D |
Year: |
2016 |
Journal: |
Nat Commun |
Title: |
Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's disease. |
Volume: |
7 |
|
Pages: |
10759 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chan G |
Year: |
2020 |
Journal: |
Am J Pathol |
Title: |
Neurodegeneration and Motor Deficits in the Absence of Astrogliosis upon Transgenic Mutant TDP-43 Expression in Mature Mice. |
Volume: |
190 |
Issue: |
8 |
Pages: |
1713-1722 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sehlin D |
Year: |
2017 |
Journal: |
Sci Rep |
Title: |
Pharmacokinetics, biodistribution and brain retention of a bispecific antibody-based PET radioligand for imaging of amyloid-β. |
Volume: |
7 |
Issue: |
1 |
Pages: |
17254 |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
human |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion, Lars Fugger |
Allele Type: |
Transgenic |
Attribute String: |
Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion, Lars Fugger |
Allele Type: |
Transgenic |
Attribute String: |
Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion, Lars M Ittner |
Allele Type: |
Transgenic |
Attribute String: |
Conditional ready, Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion, Lars Fugger |
Allele Type: |
Transgenic |
Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 1, Lars Nilsson |
Allele Type: |
Transgenic |
Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion, Lars M Ittner |
Allele Type: |
Transgenic |
Attribute String: |
Conditional ready, Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion B, Lars Nilsson |
Allele Type: |
Transgenic |
Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
Publication |
First Author: |
Israelsson C |
Year: |
2010 |
Journal: |
Eur J Neurosci |
Title: |
Appearance of Cxcl10-expressing cell clusters is common for traumatic brain injury and neurodegenerative disorders. |
Volume: |
31 |
Issue: |
5 |
Pages: |
852-63 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lord A |
Year: |
2009 |
Journal: |
FEBS J |
Title: |
Amyloid-beta protofibril levels correlate with spatial learning in Arctic Alzheimer's disease transgenic mice. |
Volume: |
276 |
Issue: |
4 |
Pages: |
995-1006 |
|
•
•
•
•
•
|
Publication |
First Author: |
Madsen LS |
Year: |
1999 |
Journal: |
Nat Genet |
Title: |
A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. |
Volume: |
23 |
Issue: |
3 |
Pages: |
343-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Moujalled D |
Year: |
2017 |
Journal: |
Hum Mol Genet |
Title: |
TDP-43 mutations causing amyotrophic lateral sclerosis are associated with altered expression of RNA-binding protein hnRNP K and affect the Nrf2 antioxidant pathway. |
Volume: |
26 |
Issue: |
9 |
Pages: |
1732-1746 |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 13, Lars M Ittner |
Allele Type: |
Transgenic |
Attribute String: |
Conditional ready, Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
CD22 antigen; targeted mutation 3, Lars Nitschke |
Allele Type: |
Targeted |
|
|
•
•
•
•
•
|
Allele |
Name: |
CD22 antigen; targeted mutation 1.1, Lars Nitschke |
Allele Type: |
Targeted |
|
|
•
•
•
•
•
|
Allele |
Name: |
CD22 antigen; targeted mutation 1, Lars Nitschke |
Allele Type: |
Targeted |
Attribute String: |
Not Specified |
|
•
•
•
•
•
|
Allele |
Name: |
CD22 antigen; targeted mutation 2, Lars Nitschke |
Allele Type: |
Targeted |
|
|
•
•
•
•
•
|
Allele |
Name: |
angiomotin-like 2; targeted mutation 1.1, Lars Holmgren |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 15, Lars M Ittner |
Allele Type: |
Transgenic |
Attribute String: |
Transactivator |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 6, Lars M Ittner |
Allele Type: |
Transgenic |
Attribute String: |
Transactivator |
|
•
•
•
•
•
|
Allele |
Name: |
TRH-degrading enzyme; targeted mutation 1, Lars Geffers |
Allele Type: |
Targeted |
Attribute String: |
Null/knockout, Reporter |
|
•
•
•
•
•
|
Allele |
Name: |
CD83 antigen; targeted mutation 1.1, Lars Nitschke |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, transgenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
transgenic, mutant strain, congenic |
|
•
•
•
•
•
|
Allele |
Name: |
angiomotin-like 1; targeted mutation 1, Lars Holmgren |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready |
|
•
•
•
•
•
|
Allele |
Name: |
deoxyribonuclease I; endonuclease-mediated mutation 1, Lars Nitschke |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(Thy1-APPSwe)1Lngn/? |
Background: |
involves: C57BL/6 * CBA |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(Thy1-APPSweArc)BLngn/? |
Background: |
involves: C57BL/6 * CBA |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(Thy1-APPSweArc)BLngn/? |
Background: |
B6J.Cg-Tg(Thy1-APPSweArc)BLngn |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Quandt JA |
Year: |
2012 |
Journal: |
J Immunol |
Title: |
Myelin basic protein-specific TCR/HLA-DRB5*01:01 transgenic mice support the etiologic role of DRB5*01:01 in multiple sclerosis. |
Volume: |
189 |
Issue: |
6 |
Pages: |
2897-908 |
|
•
•
•
•
•
|
Publication |
First Author: |
Delerue F |
Year: |
2014 |
Journal: |
Transgenic Res |
Title: |
Inducible, tightly regulated and non-leaky neuronal gene expression in mice. |
Volume: |
23 |
Issue: |
2 |
Pages: |
225-33 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ke YD |
Year: |
2015 |
Journal: |
Acta Neuropathol |
Title: |
Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS. |
Volume: |
130 |
Issue: |
5 |
Pages: |
661-78 |
|
•
•
•
•
•
|
DO Term |
|
•
•
•
•
•
|
Allele |
Name: |
microtubule-associated protein tau; targeted mutation 1.1, Lars NG Nilsson |
Allele Type: |
Targeted |
Attribute String: |
Modified isoform(s) |
|
•
•
•
•
•
|
Allele |
Name: |
neuregulin 1; targeted mutation 1, Lars E Theill |
Allele Type: |
Targeted |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Publication |
First Author: |
Wöhner M |
Year: |
2012 |
Journal: |
Eur J Immunol |
Title: |
Human CD22 cannot fully substitute murine CD22 functions in vivo, as shown in a new knockin mouse model. |
Volume: |
42 |
Issue: |
11 |
Pages: |
3009-18 |
|
•
•
•
•
•
|
Publication |
First Author: |
Özgör L |
Year: |
2016 |
Journal: |
Eur J Immunol |
Title: |
Epratuzumab modulates B-cell signaling without affecting B-cell numbers or B-cell functions in a mouse model with humanized CD22. |
Volume: |
46 |
Issue: |
9 |
Pages: |
2260-72 |
|
•
•
•
•
•
|
Publication |
First Author: |
Brandl C |
Year: |
2020 |
Journal: |
Eur J Immunol |
Title: |
Humanized CD22 transgenic mouse model for in vivo analysis of anti-CD22-based immunotherapy. |
Volume: |
50 |
Issue: |
11 |
Pages: |
1834-1837 |
|
•
•
•
•
•
|
Allele |
Name: |
immunoglobulin heavy chain complex; targeted mutation 1.1, Lars Nitschke |
Allele Type: |
Targeted |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Publication |
First Author: |
Yaylaoglu MB |
Year: |
2005 |
Journal: |
Dev Dyn |
Title: |
Comprehensive expression atlas of fibroblast growth factors and their receptors generated by a novel robotic in situ hybridization platform. |
Volume: |
234 |
Issue: |
2 |
Pages: |
371-86 |
|
•
•
•
•
•
|
Publication |
First Author: |
Geffers L |
Year: |
2004 |
Journal: |
FENS Forum Abstracts |
Title: |
Generation of thyrotropin-releasing hormone-degrading ectoenzyme (TRH-DE) deficient mice by targeted recombination |
Volume: |
2 |
|
Pages: |
A046.5 (abstr) |
|
•
•
•
•
•
|
Publication |
First Author: |
Geffers L |
Year: |
2005 |
Journal: |
MGI Direct Data Submission |
Title: |
(Production and analysis of a mouse with knock-out of the TRH-DE gene) Approved PhD dissertation: (Faculty of Natural Sciences, University of Hannover) |
|
|
|
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd22/Cd22 |
Background: |
involves: 129S4/SvJae |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd22/Cd22 |
Background: |
involves: 129P2/OlaHsd * C57BL/6 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd22/Cd22 |
Background: |
involves: 129P2/OlaHsd * C57BL/6 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd22/Cd22 |
Background: |
involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd83/Cd83 |
Background: |
involves: C57BL/6 * C57BL/6N |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Trhde/Trhde |
Background: |
involves: 129P2/OlaHsd |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Allele |
Name: |
sialic acid binding Ig-like lectin G; targeted mutation 2.1, Lars Nitschke |
Allele Type: |
Targeted |
Attribute String: |
Not Specified |
|
•
•
•
•
•
|
Allele |
Name: |
sialic acid binding Ig-like lectin G; targeted mutation 1, Lars Nitschke |
Allele Type: |
Targeted |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Publication |
First Author: |
Gumucio A |
Year: |
2013 |
Journal: |
BMC Neurosci |
Title: |
Lack of exon 10 in the murine tau gene results in mild sensorimotor defects with aging. |
Volume: |
14 |
|
Pages: |
148 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kramer R |
Year: |
1996 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Neuregulins with an Ig-like domain are essential for mouse myocardial and neuronal development. |
Volume: |
93 |
Issue: |
10 |
Pages: |
4833-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mann MA |
Year: |
2006 |
Journal: |
J Neurophysiol |
Title: |
Neuregulin effect on quantal content dissociated from effect on miniature endplate potential amplitude. |
Volume: |
96 |
Issue: |
2 |
Pages: |
671-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rimer M |
Year: |
2005 |
Journal: |
Neuroreport |
Title: |
Neuregulin-1 immunoglobulin-like domain mutant mice: clozapine sensitivity and impaired latent inhibition. |
Volume: |
16 |
Issue: |
3 |
Pages: |
271-5 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sandrock AW Jr |
Year: |
1997 |
Journal: |
Science |
Title: |
Maintenance of acetylcholine receptor number by neuregulins at the neuromuscular junction in vivo. |
Volume: |
276 |
Issue: |
5312 |
Pages: |
599-603 |
|
•
•
•
•
•
|
Allele |
Name: |
lysosomal-associated membrane protein family, member 5; endonuclease-mediated mutation 1, Lars M Ittner |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Allele |
Name: |
histocompatibility 2, class II, locus DMa; targeted mutation 1, Lars Karlsson |
Allele Type: |
Targeted |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Allele |
Name: |
family with sequence similarity 181, member B; targeted mutation 1.2, Lars Wittler |
Allele Type: |
Targeted |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Allele |
Name: |
family with sequence similarity 181, member B; targeted mutation 1.1, Lars Wittler |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready |
|
•
•
•
•
•
|
Allele |
Name: |
growth factor receptor bound protein 2; targeted mutation 1, Lars Nitschke |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
Allele |
Name: |
growth factor receptor bound protein 2; targeted mutation 1.1, Lars Nitschke |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|